{
    "ticker": "ARBB",
    "name": "Arbor Biotechnologies, Inc.",
    "description": "Arbor Biotechnologies, Inc. is a biotechnology company focused on leveraging advanced genetic engineering and synthetic biology to develop innovative therapeutic solutions. Founded in 2017, Arbor is at the forefront of biopharmaceutical research, utilizing its proprietary technology platform to engineer novel proteins and enzymes for a range of applications in medicine, agriculture, and industrial processes. The company's mission is to harness the power of nature to address pressing global health challenges and improve the quality of life for people around the world. With a diverse portfolio of projects, Arbor is particularly invested in the development of next-generation therapeutics, including gene therapies and precision medicine solutions that target genetic disorders and cancers. Arbor's team comprises leading scientists and industry experts, enabling the company to push the boundaries of biotechnology and make significant advancements in the field. As part of its commitment to sustainability and environmental stewardship, Arbor also focuses on creating eco-friendly solutions that minimize the ecological footprint of its biotechnological innovations.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Cambridge, Massachusetts, USA",
    "founded": "2017",
    "website": "https://www.arborbio.com",
    "ceo": "Dr. Rachel Haurwitz",
    "social_media": {
        "twitter": "https://twitter.com/ArborBio",
        "linkedin": "https://www.linkedin.com/company/arbor-biotechnologies/"
    },
    "investor_relations": "https://www.arborbio.com/investors",
    "key_executives": [
        {
            "name": "Dr. Rachel Haurwitz",
            "position": "CEO"
        },
        {
            "name": "Dr. John MacMillan",
            "position": "CSO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "Gene Therapies",
                "Precision Medicine Solutions"
            ]
        },
        {
            "category": "Biotechnology Tools",
            "products": [
                "Protein Engineering Platforms",
                "Enzyme Development"
            ]
        }
    ],
    "seo": {
        "meta_title": "Arbor Biotechnologies, Inc. | Innovative Biotechnology Solutions",
        "meta_description": "Explore Arbor Biotechnologies, Inc., a leader in next-generation genetic engineering and therapeutic solutions. Discover Arbor's commitment to innovation in biotechnology.",
        "keywords": [
            "Arbor Biotechnologies",
            "Biotechnology",
            "Gene Therapy",
            "Synthetic Biology",
            "Protein Engineering"
        ]
    },
    "faq": [
        {
            "question": "What does Arbor Biotechnologies specialize in?",
            "answer": "Arbor Biotechnologies specializes in genetic engineering and synthetic biology to develop innovative therapeutic solutions."
        },
        {
            "question": "Who is the CEO of Arbor Biotechnologies?",
            "answer": "Dr. Rachel Haurwitz is the CEO of Arbor Biotechnologies, Inc."
        },
        {
            "question": "Where is Arbor Biotechnologies headquartered?",
            "answer": "Arbor Biotechnologies is headquartered in Cambridge, Massachusetts, USA."
        },
        {
            "question": "What are Arbor's main products?",
            "answer": "Arbor's main products include gene therapies and precision medicine solutions, as well as biotechnology tools for protein engineering."
        },
        {
            "question": "When was Arbor Biotechnologies founded?",
            "answer": "Arbor Biotechnologies was founded in 2017."
        }
    ],
    "competitors": [
        "CRSP",
        "EDIT",
        "NVTA",
        "SGEN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "ABBV"
    ]
}